Olive oil polyphenols reduce oxysterols -induced redox imbalance and pro-inflammatory response in intestinal cells by Serra, Gessica et al.
Contents lists available at ScienceDirect
Redox Biology
journal homepage: www.elsevier.com/locate/redox
Research Paper
Olive oil polyphenols reduce oxysterols -induced redox imbalance and pro-
inflammatory response in intestinal cells
Gessica Serraa, Alessandra Incanib, Gabriele Serrelib, Laura Porrub, M.Paola Melisb,
Carlo I.G. Tuberosoc, Daniela Rossind, Fiorella Biasid, Monica Deianab,⁎
a Dept. of Food and Nutritional Sciences, University of Reading, RG6 6AP Reading, UK
bDept. of Biomedical Sciences, Unit of Experimental Pathology, University of Cagliari, 09042 Monserrato, Cagliari, Italy
c Dept. of Life and Environmental Sciences, University of Cagliari, Via Ospedale, 72, 09124 Cagliari, Italy
d Dept. of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Turin, Italy
A R T I C L E I N F O
Keywords:
Olive oil
Polyphenols
Oxysterols
Caco-2 cells
Inflammation
Oxidative stress
A B S T R A C T
Dietary habits may strongly influence intestinal homeostasis. Oxysterols, the oxidized products of cholesterol
present in cholesterol-containing foodstuffs, have been shown to exert pro-oxidant and pro-inflammatory effects,
altering intestinal epithelial layer and thus contributing to the pathogenesis of human inflammatory bowel
diseases and colon cancer. Extra virgin olive oil polyphenols possess antioxidant and anti-inflammatory prop-
erties, and concentrate in the intestinal lumen, where may help in preventing intestinal diseases. In the present
study we evaluated the ability of an extra virgin olive oil phenolic extract to counteract the pro-oxidant and pro-
inflammatory action of a representative mixture of dietary oxysterols in the human colon adenocarcinoma cell
line (Caco-2) undergoing full differentiation into enterocyte-like cells. Oxysterols treatment significantly altered
differentiated Caco-2 cells redox status, leading to oxidant species production and a decrease of GSH levels, after
1 h exposure, followed by an increase of cytokines production, IL-6 and IL-8, after 24 h. Oxysterol cell treatment
also induced after 48 h an increase of NO release, due to the induction of iNOS. Pretreatment with the phenolic
extract counteracted oxysterols effects, at least in part by modulating one of the main pathways activated in the
cellular response to the action of oxysterols, the MAPK-NF-kB pathway. We demonstrated the ability of the
phenolic extract to directly modulate p38 and JNK1/2 phosphorylation and activation of NF-kB, following its
inhibitor IkB phosphorylation. The phenolic extract also inhibited iNOS induction, keeping NO concentration at
the control level. Our results suggest a protective effect at intestinal level of extra virgin olive oil polyphenols,
able to prevent or limit redox unbalance and the onset and progression of chronic intestinal inflammation.
1. Introduction
One of the main feature of chronic gastrointestinal inflammatory
disorders, such as the inflammatory bowel diseases (IBD), is the over-
production of oxidant species, nitric oxide (NO) and pro-inflammatory
cytokines and chemokines, secreted by enterocytes and local immune
cells, which sustain and amplify inflammation and cause extensive
damage to the mucosa [1,2]. Growing evidence is accumulating toward
the strong influence of dietary components, whose metabolites exert
pro-oxidant or pro-inflammatory features, in the onset and progression
of gastrointestinal inflammatory disorders [3]. In this connection,
dietary oxidized lipids, such as oxysterols and fatty acids
hydroperoxides, together with microbiota, may influence intestinal
inflammation through different mechanisms which include direct pro-
duction of reactive species in the colon [4,5], antigenic effect, alteration
of gene expression, changes in the composition of the enteric flora and
gut permeability, and immune system deregulation [6].
Oxysterols present in food are the oxidized products of dietary
cholesterol and have been reported to reach concentrations ranging
from 10 to 100 μM [7,8]. They have been shown to potentially interfere
with the homeostasis of the human digestive tract, by promoting and
sustaining irreversible damage and dysfunction of the colonic epithelial
barrier, as demonstrated in vitro [9,10], which may lead to IBD [11]
and colon cancer [12,13]. In previous studies we showed that they may
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contribute to oxidative imbalance of the intestinal epithelium by in-
ducing the generation of oxidant species [9,11], at least in part by up-
regulating intestinal NADPH oxidase isoform 1 (NOX-1); they are also
able to up regulate interleukin (IL)− 8 and IL-6 expression and synth-
esis [14]. Their pro-inflammatory action seems to be mediated by the
modulation of redox-sensible specific mitogen-activated protein kinase
(MAPK) signaling pathways, and by activating redox-sensitive tran-
scription nuclear factor kappa B (NF-kB) [15].
Other dietary components, particularly those with antioxidant and
anti-inflammatory properties, such as phytochemicals, may be im-
portant in preventing or limiting intestinal barrier alterations [3]. Al-
though there is only a very limited number of human trials that have
focused on gastrointestinal inflammatory disorders with respect to
polyphenols intervention, several in vitro and animal studies have
shown the positive effects that polyphenols may play, in particular in
the IBD [16]. Few of them concern olive oil polyphenols and show that
an extra virgin olive oil diet enriched with phenolic compounds miti-
gate the severity of DSS-induced colitis in mice, attenuating clinical and
histological signs of damage of colonic segments, suppressing oxidative
events and inhibiting pro-inflammatory protein expression [17–21].
The main classes of extra virgin olive oil phenols are phenolic acids,
phenolic alcohols, flavonoids, secoiridoids and lignans. Most of them
have shown a broad spectrum of antioxidant, free radical scavenger and
anti-inflammatory effects [22], which makes them promising dietary
supplements in a variety of chronic inflammatory diseases, included
IBD [23–25]. The anti-inflammatory activity of olive oil polyphenols
seems to be related to their ability to inhibit the pro-inflammatory ac-
tivity of oxidants-generating enzymes, including cyclooxygenase-2
(COX-2) and inducible nitric oxide synthase (iNOS) and to modulate
different intracellular signaling pathways from NF-kB to MAPKs,
through the modulation of redox-sensible cellular networks [23].
However, the signaling pathways related to intestinal inflammation
that may be modulated by dietary oxysterols and olive oil polyphenols
still need clarifications.
In this contest, our study was aimed to evaluate the ability of an
extra virgin olive oil phenolic extract to counteract the pro-oxidant and
pro-inflammatory effect of oxysterols in intestinal cells, further ex-
ploring the molecular mechanism involved. Human colon adenocarci-
noma Caco-2 cell line spontaneously undergoes differentiation into
normal enterocyte-like cells, at about 21 days after plating [26]. Dif-
ferentiated Caco-2 cells were treated with an oxysterol mixture com-
posed by the most widely represented oxysterols in processes or/and
stored cholesterol-rich foods [27]. The phenolic extract used, was ob-
tained from a monovarietal extra virgin olive oil of Bosana cultivar, one
of the most common and widespread varieties in Sardinia (Italy), ex-
tracted trough industrial standard procedures [28]. The protective ac-
tion of the phenolic extract was evaluated as ability to modulate cel-
lular redox status alteration and MAPKs-NF-kB activation induced by
oxysterols and the inflammatory mediators acting downstream of this
pathway, IL-6 and IL-8, NO and iNOS.
2. Materials and methods
2.1. Reagents
Unless otherwise specified, all reagents and chemicals were from
Sigma-Aldrich (Milan, Italy). 5-cholesten-3β,7α-diolo (7α-hydro-
xycholesterol) and 5-cholesten-3β,7β-diolo (7β-hydroxycholesterol)
were purchased from Avanti Polar Lipids (Alabaster, Alabama, USA).
Cell culture materials were purchased from Invitrogen (Milano, Italy)
and from Lonza (Basel, Switzerland). The primary antibodies anti-
phospho-JNK 1/2, anti-JNK, anti-phospho-p38, anti-p38 and the en-
hanced chemiluminescence (ECL) reagent were purchase from
Millipore (Watford, UK). Anti-iNOS (C-11), anti-p-IκB (B-9) and anti-IκB
(9242) mouse monoclonal primary antibodies where purchased from
Santa Cruz Biotechnology (Dallas, Texas, USA). Gels and all material for
electrophoresis and immunoblotting were purchased from Invitrogen
(Milan, Italy). Nitrocellulose membranes were obtained from
Amersham (Little Chalfont, UK).
2.2. Cell culture and treatments
Human colon adenocarcinoma Caco-2 cells (ECACC Salisbury,
Wiltshire UK) were cultured in Dulbecco's modified Eagle's medium
(DMEM), supplemented with 10% heat-inactivated bovine serum,
2mM L-glutamine, 1% nonessential amino acids, 100 U/ml penicillin,
and 100 μg/ml streptomycin, in monolayers at 37 °C in a humidified
atmosphere of 5% CO2. For experimental studies Caco-2 cells, at pas-
sage 45–60, were plated and used 18–21 days post seeding, when fully
differentiated. Cells were treated with the oxysterol mixture, composed
of 42.96% 7-ketocholesterol, 32.3%, 5α,6α-epoxycholesterol, 5.76%
5β,6β-epoxycholesterol, 4.26% 7α-hydroxycholesterol, and 14.71% 7β-
hydroxycholesterol, to a final concentration of 60 μM, at different times
to locate the temporal window for investigating the activation of dif-
ferent cell signaling pathways. In a parallel set of experiment, 30min
prior to the oxysterols exposure, cells were treated with different
amounts of the phenolic extract in PBS solution (1–25 μg/ml).
2.3. Preparation of the olive oil phenolic extract
The phenolic fraction was extracted from a monovarietal extra
virgin olive oil obtained from an olive orchard located in South Sardinia
(Villasor, Cagliari, Italy). Olive trees were of Bosana cultivar, and the
oil extraction was performed in an industrial oil extraction plant fol-
lowing standard procedures by the AGRIS technicians, as previously
reported [28]. The separation of the phenolic fraction was carried out
through a liquid–liquid extraction method using MeOH/H2O 80:20 (v/
v) and phenolic components were identified and quantified by LC-DAD
analyses as previously described by Incani et al. [28].
2.4. Evaluation of IL-8 and IL-6 protein levels
Differentiated Caco-2 cells seeded in 6-well plates (5×104 cells/ml
in 2ml) were treated for 24 h with the oxysterol mixture, and pre-
treatment with the phenolic extract in a set of samples; at the end of the
incubation time the culture medium was collected and used for ELISA
detection. Levels of IL-8 and IL-6 were quantified using the Human IL-8
ELISA kit (Campoverde s.r.l., Milano, Italy) and the Human IL-6 ELISA
kit (Pantec s.r.l., Torino, Italy) following the manufacturer's instruc-
tions. Sample absorbance values were read at 450 nm with a wave-
length correction of 550 nm in a microplate reader (Model 680 micro-
plate reader Bio-Rad), and data analyzed using SlideWrite Plus software
(Advanced Graphics Software).
2.5. Measurement of nitric oxide production
In order to analyze the nitric oxide release, differentiated Caco-2
cells, seeded in 6-well plates (5×104 cells/ml in 2ml), were rinsed
with PBS and cultured for 24 h in serum-free, phenol red-free DMEM
with L-arginine 0.1 mM. A time course analysis of NO production was
performed by incubating cells from 18 to 72 h. In another set of ex-
periments cells were also pre-incubated with phenolic extract before for
30min and then incubated with oxysterols with further 24 h. At the end
of different incubation times NO production was evaluated in terms of
quantity of nitrite accumulated in the culture medium by using the
Griess’ reagent. Nitrite concentration was determined by mixing 100 μl
of the collected medium with an equal volume of Griess’ reagent and
incubating at room temperature for 15min. Absorbance values were
read at 540 nm, and nitrite levels were determined with a sodium ni-
trite standard curve ranging from 0.1 to 10 μM.
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2.6. Determination of intracellular H2O2 production
Intracellular H2O2 production was monitored in differentiated Caco-
2 cells seeded in 96-well plates (5×104 cells/ml in 100 μl). The old
medium was removed, cells were washed with 200 μl of PBS and in-
cubated for 30min with 2′,7′-dichlorofluorescin diacetate (H2-DCFH-
DA), 10 μM. H2-DCFH-DA was then replaced by the PBS solution con-
taining the phenolic extract (5–25 μg/ml), 30min prior to adding the
oxysterol mixture and incubated for 1 h. Hydrogen peroxide production
was monitored by reading the fluorescence emitted, using a micro plate
reader (Infinite 200, Tecan, Salzburg, Austria) at a controlled tem-
perature of 37 °C. The reading was performed using an excitation of
490 nm and an emission of 520 nm [29].
2.7. Determination of intracellular reduced glutathione (GSH) levels
GSH levels were determined in Caco-2 cells, grown and differ-
entiated in 6-well plates (5×104 cells/ml in 2ml). After preincubation
with the phenolic extract, cells were treated with the oxysterol mixture
for 1 h.
After treatment cells were scraped into 200 μl of ice-cold PBS and
centrifuged at 10000 g for 20min at 4 °C. The pellet was used to de-
termine GSH levels through EC-HPLC quantification (Agilent 1260 in-
finity coupled with an electrochemical detector DECADE II Antec,
Leyden, Netherlands) [29].
2.8. Immunoblotting
All experiments were performed in differentiated Caco-2 cells
seeded in 6-well plate (5×104 cells/ml in 2ml). Following treatment,
the cells were washed with ice-cold PBS prior to the addition of 180μl
CelLytic M lysis buffer for protein extraction, added with mammalian
protease and phosphatase inhibitor cocktail (1:100 v/v). Cells were
scraped on ice and lysates were incubated for 15min on ice before
centrifugation at 12500 g at 4 °C for 7min. The protein concentration
was determined by the Bradford protein assay [30].
iNOS level evaluation was performed upon immunoprecipitation:
total cell extracts (150 μg protein) were immunoprecipitated overnight
with mouse anti-iNOS polyclonal antibody (5 μl). Immunoprecipitation
was achieved by 2 h incubation at room temperature with Protein A-
Sepharose resin, and pellets were used for immunoblotting.
The samples were boiled at 90 °C for 10min in boiling buffer
(62.5 mM Tris, pH 6.8 containing 2% SDS, 5% 2-mercaptoethanol, 10%
glycerol, and 0.0025% bromophenol blue). The boiled samples were
run on 4–12% SDS–polyacrylamide gels (20 lg/lane), and the proteins
were transferred to nitrocellulose membranes (Hybond-ECL) by eBlot
Protein Transfer Device with a 7–9min transfer setup (Twinhelix,
Milan, Italy).
The nitrocellulose membrane was then incubated in a blocking
buffer (TBS) containing 4% (w/v) skimmed milk powder for 30min at
room temperature, followed by two 10min washes in TTBS. The blots
were then incubated with anti-pp38 (1:1000 dilution), anti-p38 (1/
1000 dilution), anti-pJNK 1/2 (1:1000 dilution), anti-JNK 1/2 (1:1000
dilution), anti-iNOS (1:500 dilution), anti-IκB (1:1000 dilution) and
anti-p-IκB (1:1000 dilution), in TTBS containing 1% (w/v) skimmed
milk powder (antibody buffer) overnight at 4 °C on a three-dimensional
rocking table. The blots were washed twice for 10min in TTBS and then
incubated with goat anti-rabbit and anti-mouse IgG conjugated to
horseradish peroxidase (1:2000 or 1:5000 dilution) in antibody buffer
for 45min. Finally, the blots were washed twice for 10min in TTBS,
exposed to Clarity™ Western ECL for 2–5min and developed with the
ChemiDoc™ XRS+ Imager (BioRad Laboratories, Inc., Hercules,
California, USA). The molecular weights of the bands were calculated
from comparison with pre-stained molecular weight markers that were
run in parallel with the samples (range 14–180 kDa, GenScript,
Piscataway, NJ). Protein bands were quantified using Quantity One
software (BioRad Laboratories).
2.9. Statistical analyses
Results are expressed as means± standard deviations. The statis-
tical significance of parametric differences among sets of experimental
data was evaluated by the one-way ANOVA test associated with
Bonferroni's multiple comparison post test using GraphPad InStat
(GraphPad Software, San Diego, Calif., U.S.A.).
3. Results
3.1. Olive oil phenolic extract inhibits oxysterols-induced IL-8, IL-6 and NO
production
The ability of the phenolic extract to modulate the oxysterols-in-
duced pro-inflammatory effect in Caco-2 cells was evaluated measuring
the production of IL-8, IL-6 and NO.
Treatment of Caco-2 cells with the oxysterol mixture 60 µM for 24 h
induced a significant rise of the secretion of both interleukins, doubled
in the case of IL-8 and increased by about tenfold for IL-6, as shown in
Fig. 1. Pre-treatment for 30min with the phenolic extract, 25 µg/ml, a
concentration that did not exert any cytotoxic effect (data not shown),
significantly reduced the amount of interleukins detected in the culture
medium. Oxysterols mixture was also able to induce the release of
another key inflammatory mediator, NO (Fig. 2). A time-dependent
increase of NO levels was found in the culture medium of oxysterols
treated cells, showing a significant difference compared to control
starting from 48 h of incubation. At all the tested concentrations the
phenolic extract was able to inhibit NO release at 48 h. Phenolic extract
showed no significant differences compared to control group starting
from 5 μg/ml concentration.
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Fig. 1. Modulation of IL-8 and IL-6 protein levels by oxysterols and phenolic
extract. Interleukins levels, IL-6 (A) and IL-8 (B), in differentiated Caco-2 cells
pretreated or not with the phenolic extract (25 μg/ml) for 30min and incubated
for 24 h in presence of 60 μM oxysterol mixture. Interleukins levels were also
evaluated in cells treated only with the phenolic extract (Ctrl 25). Values, ex-
pressed as percentage of the controls (control values were IL-8= 6.23 pg/ml,
IL-6= 2.87 pg/ml), represent the means± SD (n=6). *= p < 0.05 versus
control, a = p < 0.05 versus oxysterols treated cells (Oxy).
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3.2. Olive oil phenolic extract attenuates oxysterols -induced redox
imbalance
The effect of the oxysterol mixture and the phenolic extract was
then investigated in relation to the modulation of the cellular redox
status. After 1 h of incubation a significant production of oxidant spe-
cies associated with a dramatic reduction of cellular GSH, half of the
amount detected in the control samples, was observed in the cells
treated with the oxysterol mixture (Fig. 3). The presence of the phenolic
extract in the reaction environment completely inhibited the formation
of oxidant species and preserved the initial concentration of GSH.
3.3. Olive oil phenolic extract modulates the main cellular pathways
activated in response to oxysterols treatment
The ability of the phenolic extract to modulate oxysterols inter-
ference with intracellular signaling pathways involved in enterocytes
pro-inflammatory response was evaluated, focusing in particular on the
MAPKs JNK 1/2 and p38. Caco-2 cells were incubated with the oxy-
sterols mixtures for 1 h, after pre-incubation with the phenolic extract
(30min). As shown in Fig. 4A, oxysterols induced a significant increase
of JNK 1/2 phosphorylation compared to control, which, on the con-
trary, was not observed in presence of the phenolic extract. Band values
were normalized using the corresponding values of total proteins, and
expressed as a percentage of the control. Similarly, after 1 h oxysterols
treatment p38 phosphorylation was also induced. Phenolic extract
pretreatment was able to decrease, even not completely, p38 induction
(Fig. 4B). To further explore the molecular mechanism underlying the
anti-inflammatory effect of the phenolic extract, we determined its role
in NF-kB activation, by investigating as indirect marker IkB degrada-
tion. Western blot analysis showed that 60 μM oxysterol mixture
produced a significant IkB phosphorylation after 6 h treatment, which is
consistent with an up-regulation of NF-kB binding activity (Fig. 5) and
again, the phenolic extract reverted oxysterols effect. Western blot
analysis also revealed an increase of iNOS concentration after 48 h of
oxysterols treatment with respect to the control level (Fig. 5) that was
inhibited in the cells pretreated with the phenolic extract, reaching
control value at the higher concentrations tested.
4. Discussion
Dietary habits may reduce or increase the inflammatory process
linked to intestinal unbalance and damage that may lead to IBD in-
itiation and progression. The ingestion of cholesterol oxidized products
has been recently considered among the risk factors associated to the
pathogenesis of IBD, being able to alter intestinal epithelial cells
homeostasis [10,11,31,32] towards a pro-inflammatory phenotype. Our
data support the hypothesis of a direct pro-inflammatory effect of
dietary oxysterols on intestinal Caco-2 cells. As previously shown in the
same experimental conditions, incubation with a mixture of oxysterols
representative of a hyper-cholesterol diet induced a significant secre-
tion of IL-6 and IL-8, two key mediators of intestinal inflammation.
Among the cytokines released by epithelial cells IL-8 holds a pivotal
role in the recruitment of T lymphocytes and neutrophils at the site of
inflammation [33], and it is up-regulated in the colon of patients with
IBD [34]; IL-6 stimulates neutrophils chemotaxis, it is associated with
tissue destruction in the colon [35] and its serum level is correlated
with disease severity [36].
In the present work, we give the first evidence that oxysterols
treatment also stimulates Caco-2 cells to increase NO production; dif-
ferentiated Caco-2 cells constitutively produce NO, whose basal level
may be increased upon exposure to LPS or various cytokines [37,38].
Fig. 2. Lowering effect of the phenolic extract on oxysterols-induced NO re-
lease. NO levels measured as total nitrite concentration in differentiated Caco-2
cells treated with 60 μM oxysterol mixture for different incubation times (A) or
pretreated (30min) with different phenolic extract concentrations (1–25 μg/ml)
and incubated in the presence of 60 μM oxysterol mixture for 48 h (B). NO le-
vels were also evaluated in cells treated only with the phenolic extract 25 μg/ml
(Ctrl 25). Values represent the means± SD (n=9). § = p < 0.05 versus time
0; *= p < 0.05 versus control, a = p < 0.05 versus oxysterols treated cells
(Oxy).
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Fig. 3. Modulation of cell H2O2 production and GSH levels by oxysterols and
phenolic extract. A) H2O2 levels were determined in differentiated Caco-2 cells
pretreated or not with different phenolic extract concentrations (5–25 μg/ml)
for 30min and incubated for 1 h in presence of 60 μM oxysterol mixture. Cells
were further exposed to 2′,7′-dichlorodihydrofluorescein diacetate H2-DCF-DA
(10 μM) for 30min. B) GSH cell levels were measured in differentiated Caco-2
cells pretreated or not with different phenolic extract concentrations (5–25 μg/
ml) for 30min and incubated in the presence of 60 μM oxysterol mixture for 1 h.
Both H2O2 and GSH levels were also evaluated in cells treated only with the
phenolic extract 25 μg/ml (Ctrl 25). Values, expressed as percentage of the
controls (GSH control value = 28 μM), represent the means± SD (n=9). *=
p < 0.05 versus control, a = p < 0.05 versus oxysterols treated cells (Oxy).
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NO may promote, attenuate, or have little effect on gut inflammation
and injury, depending on its concentration and on the redox environ-
ment of its production. The role of iNOS-derived NO is not fully un-
derstood yet, however its sustained overproduction is considered to
promote gut inflammation [39,40]; NO may contribute to the en-
hancement of microvascular permeability, to the modulation of COX-2-
dependent production of prostaglandins [41], to the chemotaxis and
activation of leucocytes [42], and it may also rapidly interact with
certain reactive free radicals such as O2•- to yield the ONOO- oxidant
species [43]. The enhanced production of iNOS-derived NO is one of the
most consistent findings in both experimental and human IBD, together
with oxidant species production, indicating that chronically inflamed
intestinal and/or colonic tissue is subjected to significant oxidative
stress [44]. Oxysterols have been shown to promote oxidative stress
through the production of oxidant species mediated at least in part by
NOX-1 [9,11] that, depending on the concentration used, may lead to
oxidative damage [28]. In the present study, we detected a significant
production of oxidant species in Caco-2 cells treated with dietary oxy-
sterols with respect to controls, giving further evidence of their strong
pro-oxidant effect. Hydrogen peroxide increase, in particular, caused a
drop of GSH levels by profoundly altering cellular redox balance. Cel-
lular GSH levels have been shown to significantly decrease in experi-
mental IBD both at the initial disease stage [44] and when signs of
inflammation are evident [45]. Oxidized glutathione (GSSG) was found
highly increased compared with normal tissue in the inflamed mucosa
from patients with active IBD [46]. Dietary oxysterols determine oxi-
dant species overproduction and GSH levels imbalance thus likely
playing a role in the early stages of IBD.
Antioxidant supplementation may prove beneficial if able to main-
tain the cellular redox balance, directly related to both oxidative da-
mage and the modulation of redox sensible signaling pathways acti-
vated in the onset and first stages of the inflammatory process.
In this contest, we wanted to investigate the potential role of olive
oil polyphenols in preventing the oxysterols -induced redox imbalance
and pro-inflammatory phenotype in intestinal cells, as they have re-
cently been addressed as potential beneficial agents in IBD [23–25].
Ingested polyphenols are poorly absorbed; most remains in the in-
testinal lumen, mainly in the colon, where may be particularly con-
centrated [47,48], thus being able to act as direct antioxidants,
scavenging oxidant species or preventing their formation [49]. Our data
demonstrate that olive oil polyphenols are able to inhibit H2O2 and NO
production triggered by oxysterols and preserve cellular GSH levels.
The phenolic fraction extracted from extra virgin olive oil produced
from Bosana variety has been shown to have a particular high content
of phenolic compounds, mainly secoiridoids and active hydroxytyrosol,
tyrosol and oleuropein [28,50], and to exert a significant antioxidant
activity in vitro, correlated to the quantity and quality of the phenolic
content [28]. Phenols present in the extract may act through their
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Fig. 4. Modulation of JNK 1/2 and p38 phosphorylation by oxysterols and
phenolic extract. JNK 1/2 (A) and p38 (B) activation in differentiated Caco-2
cells pretreated or not with different phenolic extract concentrations (1–25 μg/
ml) for 30min and incubated in the presence of 60 μM oxysterol mixture for 1 h.
Values, expressed as percentage of the controls, represent the means± SD
(n=4). *= p < 0.05 versus control, a = p < 0.05 versus oxysterols treated
cells (Oxy). Representative WB of the treatment is shown (C).
Fig. 5. Modulation of IkB phosphorylation and iNOS levels by oxysterols and
phenolic extract. A) IkB phosphorylation in differentiated Caco-2 cells pre-
treated or not with different phenolic extract concentrations (1–25 μg/ml) for
30min and incubated in the presence of 60 μM oxysterol mixture for 6 h; B)
iNOS level in differentiated Caco-2 cells pretreated or not with different phe-
nolic extract concentrations (1–25 μg/ml) for 30min and incubated in the
presence of 60 μM oxysterol mixture for 48 h. Values, expressed as percentage
of the controls, represent the means± SD (n=4). *= p < 0.05 versus con-
trol, a = p < 0.05 versus oxysterols treated (Oxy). Representative WB of the
treatment (after IP in the case of iNOS) is shown.
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simple direct antioxidant effect as free-radical scavengers, but also in-
directly interfering with specific signaling proteins, modulated in re-
sponse to oxidative stress and pro-inflammatory stimuli.
MAPK-NF-kB pathway is of particular interest among the in-
tracellular pathways activated in IBD, because it seems to play a crucial
role during intestinal inflammatory responses [51]. NF-kB takes part
controlling the activation of various pro-inflammatory genes, leading to
the production of pro-inflammatory cytokines such as IL-6 and IL-8 and
to the expression of important inflammatory proteins such as cycloox-
ygenase-2 (COX-2) and iNOS [52]. In previous studies in differentiated
Caco-2 cells we showed that oxysterols increased the amounts of p38
and JNK phosphorylated forms and activated NF-kB [15]. Consistently,
in the experimental conditions of this study, we found that oxysterols
significantly increased the phosphorylation of the two stress-activated
MAPKs, p38 and JNK 1/2, and activate NF-kB, as shown by the phos-
phorylation of its inhibitor IkB. p38 phosphorylation is increased sig-
nificantly in IBD tissue [53,54] and in vitro and in vivo studies indicate
that p38 activation mediates, among several downstream events in-
duced in immune and non-immune cells [55], the production of IL-6
and IL-8 via NF-kB activation [56,57]. Like p38, phosphorylated JNK1/
2 are found highly concentrated in inflamed tissue from IBD patients
[54,58], it seems to contribute to the maturation and activation of
immune cells and synthesis of different pro-inflammatory cytokines,
however its role in IBD is controversial [59,60].
Olive oil phenolic fraction has been shown to interact with MAPKs
in LPS stimulated murine peritoneal macrophages, where a reduction of
JNK and p38 phosphorylation resulted in an anti-inflammatory effect,
blocking NF-kB activation [61]. In our Caco-2 cell cultures the phenolic
extract was able to revert the oxysterols driven activation of JNK and
p38 and subsequent phosphorylation of IkB. The inhibition of NF-kB
activation may explain the lower concentration of Il-6 and Il-8 detected
in the medium after oxysterols stimulation in presence of the phenolic
extract. NF-kB is also involved in NO production via iNOS expression
[52]. In the present study we found that exposure of Caco-2 cells to
oxysterols resulted in a significant increase of NO production due to an
upregulation of iNOS concentration, and treatment with the phenolic
extract inhibited these effects.
The efficacy of the phenolic extract may be due to a possible sy-
nergic effect among the different compounds present in the same
fraction, considering that some of them have been proven to interact
with MAPKs and NF-kB signaling pathway. A few studies in vitro
showed the ability of hydroxytyrosol to block NF-kB activation and
iNOS and COX-2 expressions [61–63]. In vivo studies also indicate an
anti-inflammatory effect of hydroxytyrosol and oleuropein exerted
through the modulation of MAPKs signaling [23,64].
Taken together our data clearly show that intestinal epithelial cells
represent a direct target of the action of dietary oxysterols, giving
further evidence of their possible implication in IBD development. Our
results also suggest a significant protective effect at intestinal level of
extra virgin olive oil polyphenols, strengthening the link between diet
and IBD pathogenesis and progression. The inhibitory effects of olive oil
total phenolic fraction on some key inflammatory mechanisms such as
NF-kB activation, iNOS induction and IL-8 and IL-6 production, provide
strong evidence that it is able to prevent or delay the progression of
intestinal inflammation. Considering that also oleic acid, which re-
presents the highly concentrated monounsaturated fatty acid in olive
oil, has been proven to reduce colonic inflammation [65], extra virgin
olive oil consumption may be considered a useful tool in the prevention
and management of IBD.
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